A clinical evaluation of an ex vivo organ culture system to predict patient response to cancer therapy
IntroductionEx vivo organ cultures (EVOC) were recently optimized to sustain cancer tissue for 5 days with its complete microenvironment. We examined the ability of an EVOC platform to predict patient response to cancer therapy.MethodsA multicenter, prospective, single-arm observational trial. Sampl...
Main Authors: | Shay Golan, Vered Bar, Seth J. Salpeter, Guy Neev, German Creiderman, Daniel Kedar, Sara Aharon, Lubov Turovsky, Adi Zundelevich, Hamutal Shahar, Hagit Shapira, Giuseppe Mallel, Erez Stossel, Nancy Gavert, Ravid Straussman, Zohar Dotan, Raanan Berger, Chani Stossel, Talia Golan, Sharon Halperin, Dan Leibovici, Shani Breuer, Yakir Rottenberg, Liat Applebaum, Ayala Hubert, Hovav Nechushtan, Tamar Peretz, Aviad Zick, Boris Chertin, Dmitry Koulikov, Amir Sonnenblick, Eli Rosenbaum |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1221484/full |
Similar Items
-
Update on current and new potential immunotherapies in breast cancer, from bench to bedside
by: Emmanuelle Alaluf, et al.
Published: (2024-02-01) -
Temporal trends of geographic variation in mortality following cancer diagnosis: a population-based study
by: Yakir Rottenberg, et al.
Published: (2019-01-01) -
The History of Early Breast Cancer Treatment
by: Judith Ben-Dror, et al.
Published: (2022-05-01) -
Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations
by: Johnathan Arnon, et al.
Published: (2023-09-01) -
Comparing Intraperitoneal and Intravenous Personalized ErbB2CAR-T for the Treatment of Epithelial Ovarian Cancer
by: Naamit Deshet-Unger, et al.
Published: (2022-09-01)